Skip to main content
Premium Trial:

Request an Annual Quote

Nelson Chan

Twist Bioscience has appointed Nelson Chan to its board of directors. Chan has been an advisor to Twist for the last 18 months for the firm's DNA data storage business. Chan is also chairman of the board at Synaptics and Adesto, as well as executive chairman of HZO. He previously served as CEO of Magellan and has also held various senior management roles at SanDisk Corporation. Chan will replace Paul Conley, managing director of Paladin Capital Group, who has served on Twist's board since 2013.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.